Ferrara N - Search Results

1

PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment.

Crawford Y, Kasman I, Yu L, Zhong C, Wu X, Modrusan Z, Kaminker J, Ferrara N. Crawford Y, et al. Among authors: ferrara n. Cancer Cell. 2009 Jan 6;15(1):21-34. doi: 10.1016/j.ccr.2008.12.004. Cancer Cell. 2009. PMID: 19111878 Free article.

2

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

Park JE, Keller GA, Ferrara N. Park JE, et al. Among authors: ferrara n. Mol Biol Cell. 1993 Dec;4(12):1317-26. doi: 10.1091/mbc.4.12.1317. Mol Biol Cell. 1993. PMID: 8167412 Free PMC article.

3

The role of vascular endothelial growth factor in pathological angiogenesis.

Ferrara N. Ferrara N. Breast Cancer Res Treat. 1995;36(2):127-37. doi: 10.1007/BF00666035. Breast Cancer Res Treat. 1995. PMID: 8534862 Review.

4

Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.

Presta LG, Chen H, O'Connor SJ, Chisholm V, Meng YG, Krummen L, Winkler M, Ferrara N. Presta LG, et al. Among authors: ferrara n. Cancer Res. 1997 Oct 15;57(20):4593-9. Cancer Res. 1997. PMID: 9377574

5

Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor.

Pham CD, Roberts TP, van Bruggen N, Melnyk O, Mann J, Ferrara N, Cohen RL, Brasch RC. Pham CD, et al. Among authors: ferrara n. Cancer Invest. 1998;16(4):225-30. doi: 10.3109/07357909809039771. Cancer Invest. 1998. PMID: 9589031

6

Oncogenic ras fails to restore an in vivo tumorigenic phenotype in embryonic stem cells lacking vascular endothelial growth factor (VEGF).

Shi YP, Ferrara N. Shi YP, et al. Among authors: ferrara n. Biochem Biophys Res Commun. 1999 Jan 19;254(2):480-3. doi: 10.1006/bbrc.1998.9966. Biochem Biophys Res Commun. 1999. PMID: 9918864

7

Efficacy and concentration-response of murine anti-VEGF monoclonal antibody in tumor-bearing mice and extrapolation to humans.

Mordenti J, Thomsen K, Licko V, Chen H, Meng YG, Ferrara N. Mordenti J, et al. Among authors: ferrara n. Toxicol Pathol. 1999 Jan-Feb;27(1):14-21. doi: 10.1177/019262339902700104. Toxicol Pathol. 1999. PMID: 10367667

8

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation.

Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. Gerber HP, et al. Among authors: ferrara n. Nat Med. 1999 Jun;5(6):623-8. doi: 10.1038/9467. Nat Med. 1999. PMID: 10371499

9

Molecular and biological properties of vascular endothelial growth factor.

Ferrara N. Ferrara N. J Mol Med (Berl). 1999 Jul;77(7):527-43. doi: 10.1007/s001099900019. J Mol Med (Berl). 1999. PMID: 10494799 Review.

10

Clinical applications of angiogenic growth factors and their inhibitors.

Ferrara N, Alitalo K. Ferrara N, et al. Nat Med. 1999 Dec;5(12):1359-64. doi: 10.1038/70928. Nat Med. 1999. PMID: 10581076 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

682 results

Search Page

Filters